tetrathiomolybdate
Tetrathiomolybdate (TM) is used in the clinic for the treatment of Wilson’s disease by inducing dimerization of the metal-binding domain of the cellular copper efflux protein ATP7B (WLN4) through a unique sulfur-bridged Mo2S6O2 cluster.
Supplier | Selleck Chemicals |
---|---|
Product # | E1166 |
Sku # | E1166-5mg |
Pricing | 5mg, $290.00 |